Connect with us

Business

Credence launches the COVID Diagnostics Center

Published

on

Credence Genomics, trail blazers in the area of genome diagnostics, has launched the COVID Diagnostics Center to cater for the needs of COVID RT-qPCR testing in Sri Lanka. The company announced last week.

The COVID Diagnostics Center is a diagnostic grade facility with the capacity to deliver over 6,000 tests, a four- hour reporting time and a lab time of 70 mins. Credence CDC President Dr. Sarath Paranavitane, an industry veteran who has been involved in many important local and international healthcare projects  that cater to high quality testing and patient care, who will be heading the Centre said. 

“The vision behind the COVID Diagnostics Center (CDC) is to serve the need for rapid high quality PCR testing where a patient can conduct the gold standard qPCR test within three hours based on enhanced technology investments. The unit uses robotic magnetic bead extractors from Pentabase Denmark, a leader in RNA extraction and qPCR. The units are used in major airports, and health institutions including Sri Lanka’s BIA lab which conducted 100,00 tests on this  platform recently”, said Paranavitane.

Credence CDC also uses diagnostic grade approved RT-qPCR machines from leading suppliers in a purpose-built facility designed specifically to prevent contamination, while  a team of award-winning Lankan scientists with global delivery experience is behind every single test. The facility follows strict decontamination and fogging protocols ensuring the integrity of the unit and in turn each sample, a news release said.

“Each sample is registered online, and sample integrity is checked through multiple quality control parameters, while Credence only works with collectors who are evaluated and certified by a consultant microbiologist or virologist”.

Paranavitane went on to say that the COVID Diagnostic Center has been conceived to respond to the national need for high quality, rapid, and precise PCR testing. An early test result will enable  the Sri Lankan  workforce to take prompt  action in keeping with the government guidelines which in turn will help the workforce to return to work early and ensure smooth functioning of the organization.

“A test of this speed, accuracy and cost effectiveness will reduce the government burden by encouraging early home isolation and also curtail spread of COVID 19.”

The uniqueness of the Credence lab vis-a- vis other facilities includes the fact that it is the only facility that could perform 6,000 tests per day and give a report in four hours, the entire process from collection point to generation of a report can be viewed on line by an access given from  a dedicated portal, and all tests are done on a diagnostic platform as opposed to a research platform with no pooling of samples.

The process is automated with minimal human interaction thereby ensuring 100 % accuracy. Every report  carries the CT value in compliance with WHO and CDC  guidelines, while the team of collectors are trained and certified by a consultant microbiologist and consultant physician [Dr Paranavitane] on an ongoing basis, with weekly reviews.

 “Collection of samples as you are aware is the first most important step in this process of PCR testing as if this is  not done properly, the subsequent steps  leading  to report generation becomes a futile exercise” said Paranavitane.

CEO, Credence Genomics Dr. Vaz Gnanam  said “the COVID Diagnostic Center is an amalgamation of scientists, healthcare professionals, and the most advanced technology along with data systems and processes under the exemplary leadership of Dr. Sarath Paranavitane  in response to the national crisis caused by COVID. Credence Genomics considers it  a privilege to serve our nation at this time of crisis.

Dr. Vaz Gnanam futher said that Credence Genomics is honoured to join hands with the Central Medical Centre (PVT) Ltd. at Kohuwala – a longstanding and reputed family practice of Dr.Sarath Paranavitane’s to take forward the concept of next generation sequencing in cancer management at both primary and secondary healthcare levels

Credence Genomics (Pvt) Limited is Sri Lanka’s first and foremost clinical genomics laboratory to provide high throughput, high quality next generation sequencing services. Credence Genomics services both international and local genetic testing markets by exporting high quality testing services and products. A long term collaboration with Apollo Hospitals in India , has seen Credence’s unique infectious disease Bactfast and Fungifast being used across the board at arguably  the largest South Asian healthcare services provider. Credence Genomics has forged many partnerships globally and delivers their oncology and fertility range apart from the award winning dxn1 – infectious disease range.

 

 



Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Foreign Minister defends India pacts, sidesteps transparency demand

Published

on

The press conference held at the Foreign Ministry in Colombo yesterday. From left:Arun Hemachandra, Deputy Minister of Foreign Affairs, Vijitha Herath, Minister of Foreign Affairs and Tourism and Prof. Ruwan Ranasinghe, Deputy Minister of Tourism

In a press conference marked by both clarity and pointed omission, Foreign Affairs and Tourism Minister Vijitha Herath, yesterday offered a robust defence of two controversial bilateral agreements with India but conspicuously avoided committing to tabling their full texts in Parliament.

The minister’s appearance, billed as a year-opening briefing, took a sharp turn when questioned on the strategic implications of the India-Sri Lanka Defence Cooperation Agreement and Sri Lanka’s acceptance of the Indian Pharmacopoeia.

“No Indian military camps on our soil”

Responding in Sinhala to a question posed in English, Minister Herath moved first to allay what he suggested were widespread misapprehensions about the defence pact.

“This agreement is especially for data and information exchange purposes regarding drug trafficking, drug mafias, human trafficking, and any terrorist activities that could threaten regional security and peace,” Herath stated.

He emphasised that it would also facilitate “various support related to the defence sector.”

In his most definitive assertion, aimed at quieting a persistent national anxiety, the Minister declared: “We must clearly say that there is no plan or possibility of setting up Indian defence camps on Sri Lankan soil.” He categorised the pact not as a “defence agreement” but a “defence cooperation agreement in its real sense,” claiming it creates an “advantageous position” for Sri Lanka.

He linked recent post-‘Ditwah’ cyclone disaster support from India, as well as U.S. aerial support during recovery efforts, to the frameworks established by such cooperation agreements, arguing they have proven beneficial.

Indian Pharmacopoeia: A reputation-based advantage

On the equally contentious acceptance of the Indian Pharmacopoeia – a standard synopsis for drug manufacturing – Minister Herath framed it as a logical step that formalises existing practice.

“We already import a significant share of medicines from India,” he noted. The agreement, he explained, signifies the acceptance of medicines exported by a “reputed Indian pharmaceutical company” approved by its national regulators.

He assured the public that Sri Lanka’s National Medicine Regulatory Authority (NMRA) will continue to remain the monitor. “By entering into this, no disadvantage will happen to us. Only an advantage will happen… it will only be beneficial to us,” he emphasised.

The unanswered question

Despite the detailed assurances, the Minister pointedly ignored the final and arguably most critical part of the question posed by The Island Financial Review : whether the government would table the full text of the two agreements in Parliament for transparent debate and discussion.

This omission is likely to fuel further controversy, as opposition parties, civil society groups, and independent analysts have repeatedly demanded full parliamentary scrutiny, arguing that agreements touching on sovereignty and public health mandate the highest level of public transparency.

Tourism Pride

Shifting to his tourism portfolio, Minister Herath struck an optimistic note, citing record tourist arrivals and foreign remittances in 2025 as a sign of resilient recovery post-Ditwah.

The conference also touched on global affairs. When asked about the U.S. arrest of Venezuelan President Nicolás Maduro, Herath presented a nuanced governmental position. He stated that while his party, the JVP, condemns the action, the government’s official stance is to urge respect for national sovereignty in line with the UN Charter – a reflection of the coalition’s delicate balancing act between ideological roots and diplomatic pragmatism once in governance.

Minister Herath’s explanations provide the government’s clearest public rationale yet for the India agreements, directly confronting fears over militarisation and pharmaceutical quality. However, the deliberate sidestepping of the transparency query left a communication deficit at the heart of the press conference.

High-stakes diplomacy

It reflected a perception that while the administration is willing to defend its policy outcomes, it remains reluctant to subject the processes of high-stakes diplomacy to the full glare of parliamentary and public scrutiny. As these agreements continue to shape Sri Lanka’s strategic and health landscape, the call for their full disclosure is now accompanied by a louder question about the government’s commitment to open governance.

by Sanath Nanayakkare

Continue Reading

Business

‘Vehicle-Testing Can Save Lives’

Published

on

Dharmasiri Gamage, Director, Presidential Secretariat, (4th from left), receiving the proposal from Prasanna De Zoysa (2nd from left), AAC Sectoral Chairman, Road Safety and Devapriya Hettiarachchi (3rd from left), Secretary, AAC at the Presidential Secretariat.

Automobile Association of Ceylon (AAC), in collaboration with the Federation Internationale de L’ Automobile (FIA) and under the UN Decade of Action for Road Safety has been consistently engaging in road safety enhancement programs for all citizens of Sri Lanka.

Current data indicates that while over 08 million vehicles are registered in the country, only heavy vehicles (less than 20% of the vehicle population) are subjected to compulsory road-worthiness tests.

Fatal accidents due to technical failures in vehicles are on the rise and the damage to lives and property is severe.

We also understand that there is a death every three hours and eight deaths per day in road accidents. This amounts to nearly 3000 deaths in road accidents per year.

AA of Ceylon has launched the “Vehicle Testing can Save Lives” project with the advice and support given to execute our campaign by the Minister of Transport, chairman, National Council for Road Safety (NCRC), Deputy Inspector General of Police (Traffic Division), Dr. Indika Jagoda, Deputy Director (Accident Service), National Hospital, president, Lions Club of Boralasgamuwa, Metro(Lions Club International – District 306 D 2) and other stake-holders to find a workable, low / cost solution for mandatory vehicle testing in Sri Lanka.

Therefore, this project aims to educate the public on the necessity of checking essential safety features in all vehicles and the benefits of same to all road users.

AAC has therefore respectfully requested Anura Kumara Dissanayake, President of the Democratic Socialist Republic of Sri Lanka, to consider implementing the proposal we have submitted to him, to minimize fatal accidents, injuries to people and damage to vehicles and property due to road accidents and to also implement a rule to have compulsorily road-worthiness checking of all vehicles. (AAC)

Continue Reading

Business

INSEE Lanka appoints new Chief Executive Officer

Published

on

Eng. Thusith C. Gunawarnasuriya

Siam City Cement (Lanka) Limited (INSEE Lanka) has announced the appointment of Eng. Thusith C. Gunawarnasuriya as its new Chief Executive Officer, effective 01 January 2026. He succeeds Nandana Ekanayake, who will continue to serve as Chairman, ensuring leadership continuity and strategic stability for the organisation.

A long-standing contributor to INSEE’s journey, Thusith has worked with the company through its evolution under Holcim (Lanka) Ltd, LafargeHolcim and INSEE, playing pivotal roles that influenced both operational progress and strategic direction.

Rejoining INSEE Lanka in January 2025 as Chief Operating Officer, he has since demonstrated exceptional leadership, driving topline growth, improving EBITDA performance, and strengthening talent development initiatives that enhanced organisational capability and business outcomes.

His expertise in business strategy, operations excellence, and supply chain transformation is well-recognised, supported by over 25 years of multi-industry and multi-country leadership experience. His career includes senior positions at Lion Brewery (Ceylon) PLC, Hemas Manufacturing, Fonterra Brands Lanka, GlaxoSmithKline, MAS Active, and DMS Software Engineering. His international exposure spans India, Bangladesh, and Thailand.

Thusith is a proud alumnus of Dharmaraja College, Kandy, and holds a BSc (Hons) in Electrical & Electronic Engineering from the University of Peradeniya, an MBA from the University of Colombo, and an MSc in Business & Organizational Psychology from Coventry University, UK. He has completed executive leadership programs at IMD (Switzerland) and the National University of Singapore. He is also a member of IEEE (US), CILT (UK), ISMM (Sri Lanka), and IESL (Sri Lanka).

Chairman’s Quote – Nandana Ekanayake:

“Thusith’s deep understanding of our business, strong operational mindset, and proven leadership make him the ideal successor to lead INSEE Lanka into the next phase of growth. His experience within INSEE and across multiple industries, positions him well to deliver on our long-term ambitions and uphold the values that define the organisation.”

Continue Reading

Trending